1. Li, Xin, Chen, Xiaowei, Hu, Xueju, Wu, Leilei, Shen, Xiaobing. 2021. Overexpression of GUCY1A2 Correlates With Poor Prognosis in Gastric Cancer Patients. In Frontiers in oncology, 11, 632172. doi:10.3389/fonc.2021.632172. https://pubmed.ncbi.nlm.nih.gov/34113559/
2. Wittrien, Theresa, Ziegler, Alban, Rühle, Anne, Coutant, Régis, Behrends, Sönke. . Heterozygous gain of function variant in GUCY1A2 may cause autonomous ovarian hyperfunction. In European journal of endocrinology, 190, 266-274. doi:10.1093/ejendo/lvae030. https://pubmed.ncbi.nlm.nih.gov/38578777/
3. Zhao, Deze, Dong, Yeping, Duan, Minghao, Gao, Yang, Duan, Chaojun. 2023. Circadian gene ARNTL initiates circGUCY1A2 transcription to suppress non-small cell lung cancer progression via miR-200c-3p/PTEN signaling. In Journal of experimental & clinical cancer research : CR, 42, 229. doi:10.1186/s13046-023-02791-1. https://pubmed.ncbi.nlm.nih.gov/37667322/
4. Khan, Raiyan R, Guerrero, Rafael F, Wapner, Ronald J, Pe'er, Itsik, Haas, David M. 2024. Genetic polymorphisms associated with adverse pregnancy outcomes in nulliparas. In Scientific reports, 14, 10514. doi:10.1038/s41598-024-61218-9. https://pubmed.ncbi.nlm.nih.gov/38714721/
5. Wu, Xize, Pan, Xue, Zhou, Yi, Gong, Lihong, Li, Yue. 2024. Identification of key genes for atherosclerosis in different arterial beds. In Scientific reports, 14, 6543. doi:10.1038/s41598-024-55575-8. https://pubmed.ncbi.nlm.nih.gov/38503760/
6. Huang, Sicong, Chen, Ruiqi, Gao, Shihua, Shen, Gang, Jia, Hongyun. 2022. Identification of Diagnostic Markers in Infantile Hemangiomas. In Journal of oncology, 2022, 9395876. doi:10.1155/2022/9395876. https://pubmed.ncbi.nlm.nih.gov/36504560/
7. Susmi, Tasmina Ferdous, Rahman, Atikur, Khan, Md Moshiur Rahman, Batiha, Gaber El-Saber, Hossain, Mohammad Uzzal. 2021. Prognostic and clinicopathological insights of phosphodiesterase 9A gene as novel biomarker in human colorectal cancer. In BMC cancer, 21, 577. doi:10.1186/s12885-021-08332-3. https://pubmed.ncbi.nlm.nih.gov/34016083/